Verition Fund Management’s Kinnate Biopharma Inc. Common Stock KNTE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-70,000	Closed	-$98K	–	2296
2023 Q3	$98K	Sell	70,000 -23,345	-25%	-$32.7K	﹤0.01%	1768
2023 Q2	$283K	Buy	+93,345	New	+$283K	﹤0.01%	1377